EP4201425A4 - REVERSIBLE OPENING AGENT FOR VASCULAR BARRIER OF NERVOUS SYSTEM - Google Patents

REVERSIBLE OPENING AGENT FOR VASCULAR BARRIER OF NERVOUS SYSTEM Download PDF

Info

Publication number
EP4201425A4
EP4201425A4 EP21858367.2A EP21858367A EP4201425A4 EP 4201425 A4 EP4201425 A4 EP 4201425A4 EP 21858367 A EP21858367 A EP 21858367A EP 4201425 A4 EP4201425 A4 EP 4201425A4
Authority
EP
European Patent Office
Prior art keywords
nervous system
opening agent
vascular barrier
reversible opening
reversible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21858367.2A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP4201425A1 (en
Inventor
Eiji Ikeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamaguchi University NUC
Original Assignee
Yamaguchi University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamaguchi University NUC filed Critical Yamaguchi University NUC
Publication of EP4201425A1 publication Critical patent/EP4201425A1/en
Publication of EP4201425A4 publication Critical patent/EP4201425A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/52—Isomerases (5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP21858367.2A 2020-08-21 2021-08-19 REVERSIBLE OPENING AGENT FOR VASCULAR BARRIER OF NERVOUS SYSTEM Pending EP4201425A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020139886 2020-08-21
PCT/JP2021/030373 WO2022039223A1 (ja) 2020-08-21 2021-08-19 神経系血管バリアーの可逆的開口剤

Publications (2)

Publication Number Publication Date
EP4201425A1 EP4201425A1 (en) 2023-06-28
EP4201425A4 true EP4201425A4 (en) 2024-09-04

Family

ID=80323509

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21858367.2A Pending EP4201425A4 (en) 2020-08-21 2021-08-19 REVERSIBLE OPENING AGENT FOR VASCULAR BARRIER OF NERVOUS SYSTEM

Country Status (4)

Country Link
US (1) US20230302082A1 (https=)
EP (1) EP4201425A4 (https=)
JP (1) JP7761277B2 (https=)
WO (1) WO2022039223A1 (https=)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006212721A1 (en) * 2005-02-10 2006-08-17 The University Of Western Australia Neuroprotective agents and methods of their use
US20120156221A1 (en) * 2009-06-19 2012-06-21 Ludivine Perrocheau Method and Pharmaceutical Composition for Use in the Treatment of Neurodegenerative Disorders
US20160220649A1 (en) * 2013-09-13 2016-08-04 Fundación Pública Andaluza Progreso Y Salud Combinations of aggregating proteins and molecular chaperone proteins for the treatment of proteinopathies or conformational diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1846107A1 (en) * 2005-02-10 2007-10-24 The University Of Western Australia Neuroprotective agents and methods of their use
KR20170085595A (ko) 2014-12-10 2017-07-24 제넨테크, 인크. 혈뇌 장벽 수용체 항체 및 사용 방법
JP6818358B2 (ja) 2015-10-29 2021-01-27 国立大学法人山口大学 神経系血管バリアーの機能回復剤及び神経系疾患治療剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006212721A1 (en) * 2005-02-10 2006-08-17 The University Of Western Australia Neuroprotective agents and methods of their use
US20120156221A1 (en) * 2009-06-19 2012-06-21 Ludivine Perrocheau Method and Pharmaceutical Composition for Use in the Treatment of Neurodegenerative Disorders
US20160220649A1 (en) * 2013-09-13 2016-08-04 Fundación Pública Andaluza Progreso Y Salud Combinations of aggregating proteins and molecular chaperone proteins for the treatment of proteinopathies or conformational diseases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BOULOS ET AL: "Evidence that intracellular cyclophilin A and cyclophilin A/CD147 receptor-mediated ERK1/2 signalling can protect neurons against in vitro oxidative and ischemic injury", NEUROBIOLOGY OF DISEASE, ELSEVIER, AMSTERDAM, NL, vol. 25, no. 1, 21 November 2006 (2006-11-21), pages 54 - 64, XP005749150, ISSN: 0969-9961, DOI: 10.1016/J.NBD.2006.08.012 *
See also references of WO2022039223A1 *

Also Published As

Publication number Publication date
US20230302082A1 (en) 2023-09-28
WO2022039223A1 (ja) 2022-02-24
JPWO2022039223A1 (https=) 2022-02-24
EP4201425A1 (en) 2023-06-28
JP7761277B2 (ja) 2025-10-28

Similar Documents

Publication Publication Date Title
EP3861822A4 (en) SYSTEMS AND METHODS FOR RANDOM TWO-STEP ACCESS PROCEDURE
EP3583507A4 (en) BLOCKCHAIN-BASED ADMISSION PROCESS FOR PROTECTED ENTITIES
EP4380665A4 (en) INTRAVASCULAR GUIDEWIRE AND MICROCATHETER SYSTEM
CL2020003334S1 (es) Porción de automóvil.
EP4157427A4 (en) VASCULAR ACCESS CATHETER
EP3746460A4 (en) COMPOUNDS CROSSING THE BLOOD-BRAIN BARRIER AND THEIR USES
EP3659957A4 (en) ELEVATOR CAB DOOR MACHINE DEVICE
DK3975942T3 (da) Magnesium-baserede absorberbare legeringer
EP3460088A4 (en) STEEL SHEET
EP3475258A4 (en) INNOVATIVE CONNECTION FOR INDUCING AUTOPHAGIE ACTIVATION AGAINST SKIN INFLAMMATION OR AGING
EP3538192A4 (en) SYSTEMS AND METHODS FOR PERCUTANEOUS INTRAVASCULAR ACCESS AND GUIDEWIRE PLACEMENT
EP4065242C0 (de) Lanze, insbesondere löschlanze für die brandbekämpfung
EP3502296A4 (en) STEEL
IL284653A (en) Memories of liquid coins
EP3610848A4 (en) SKIN CLEANSING COMPOSITION
EP3801897A4 (en) Catalyst compositions for hydroformylation and methods of use thereof
EP4201425A4 (en) REVERSIBLE OPENING AGENT FOR VASCULAR BARRIER OF NERVOUS SYSTEM
EP4162938A4 (en) ANTIMICROBIAL AGENT FOR NON-HUMAN ANIMALS
IL262794A (en) An inhibitor of the expression of a pro-inflammatory factor, a masking method for its active component, a useful expression cassette for said method, a diagnostic factor and a diagnosis method
EP3610850A4 (en) SKIN CLEANSING COMPOSITION
IT201700121764A1 (it) Composizione per il trattamento e/o la prevenzione di patologie neurodegenerative.
EP4415796A4 (en) IMPROVED CEREBRAL ANGIOGRAPHY CATHETER
EP4104861A4 (en) Therapeutic agent for tauopathies
EP4259608A4 (en) TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS
EP4190337A4 (en) THERAPEUTIC AGENT FOR NERVOUS FUNCTION DISORDER

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230303

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20240801

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 9/90 20060101ALI20240726BHEP

Ipc: A61K 9/00 20060101ALI20240726BHEP

Ipc: A61K 38/52 20060101ALI20240726BHEP

Ipc: A61K 38/16 20060101ALI20240726BHEP

Ipc: A61K 38/00 20060101ALI20240726BHEP

Ipc: A61K 47/42 20170101ALI20240726BHEP

Ipc: C07K 14/47 20060101ALI20240726BHEP

Ipc: A61P 43/00 20060101ALI20240726BHEP

Ipc: A61P 35/00 20060101ALI20240726BHEP

Ipc: A61P 27/02 20060101ALI20240726BHEP

Ipc: A61P 25/18 20060101ALI20240726BHEP

Ipc: A61P 25/08 20060101ALI20240726BHEP

Ipc: A61P 25/00 20060101ALI20240726BHEP

Ipc: A61P 9/00 20060101ALI20240726BHEP

Ipc: A61K 45/06 20060101ALI20240726BHEP

Ipc: A61K 45/00 20060101AFI20240726BHEP